Comparative Genomics Reveals Distinct Immune-oncologic Pathways in African American Men with Prostate Cancer.
Shivanshu AwasthiAnders E BerglundJulieta Abraham-MirandaRobert J RounbehlerKevin H KenslerAmparo SernaAdriana VidalSungyong YouMichael R FreemanElai DavicioniYang LiuR Jeffrey KarnesEric A KleinRobert B DenBruce J TrockJoshua D CampbellDavid J EinsteinRaavi GuptaSteven P BalkPriti LalJong Y ParkJohn L ClevelandTimothy R RebbeckStephen J FreedlandKosj YamoahPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2020)
Prostate tumors of AAM manifest a unique immune repertoire and have significant enrichment of proinflammatory immune pathways that are associated with poorer outcomes. Observed immune-oncologic differences can aid in a genomically adaptive approach to treating prostate cancer in AAM.